Highlights Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Market Closed - Canadian Securities Exchange Other stock markets 11:18:24 27/06/2024 pm IST			5-day change	1st Jan Change
0.01 ^CAD	0.00%		-50.00%	-80.00%

26/03	Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	MT
26/03	An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	26/03	CI
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03	MT
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	11/03	CI
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02	CI
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	26/01	MT
Psyence Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11/11	CI
Psyence Group Inc. Designs New Laboratory at Facility in Order to Expand its Extraction Capabilities	30/23/30	CI
Psyence Group Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	29/23/29	CI
Psyence Group Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	28/23/28	CI
Psyence Group Inc. Partners with iNGEN for Palliative Care Clinical Trial in Australia	21/23/21	CI
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	01/23/01	CI
Psyence Group and Eden Labs Announce Extraction and Product Development Collaboration	24/23/24	MT
Psyence Group Inc. and Eden Labs LLC Announces Extraction and Product Development Collaboration	24/23/24	CI
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK	20/23/20	CI
Psyence Group Completes Export of Pharma Grade Psilocybin Extract to UK	20/23/20	MT
Refile: Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	10/23/10	MT
Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	10/23/10	MT
Psyence Group Inc. Signs Letter of Intent with INGENu CRO Pty Ltd	09/23/09	CI
Psyence and Filament Health Announce Licensing Agreement of Psilocybin Capsule for Palliative Care	15/22/15	MT
Filament Health and Psyence Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care	15/22/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Highlights

Filters